System Transmission

Top Signal

100#1 JOB

Activity

2162Ripe

+916 today

System

Livenow

Terminal Asset View

stockNASDAQ

IMVT

$24.41-2.32%

Immunovant Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

23Overripe

Live Analysis Active

Company Mission

Immunovant creates antibody-based medicines that help treat autoimmune diseases where the body's immune system attacks healthy cells. These treatments are designed for patients with conditions like thyroid eye disease and myasthenia gravis. The company makes money through research partnerships and hopes to generate revenue from drug sales if its treatments receive regulatory approval.

IMV

Industry Context

Biotechnology companies develop medical treatments through scientific research. This sector experiences significant price swings when clinical trial results are announced or regulatory decisions are made. Companies with promising drug candidates often attract investor attention during these periods.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

71Matrix

Market Momentum

33.7— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

1.1x— Normal Volume

Today's Change

-2.32%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing IMVT across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 08:33 PM UTC

As-of 03-14-2026 20:18 UTC

Develops antibody treatments for autoimmune diseases and makes money by selling these drugs to hospitals and pharmacies.

Weekly chart shows price coiling in a tight range near recent lows, suggesting a potential breakout move is building.

Biotech sector showing volatility as FDA decisions approach, creating opportunities for companies with promising clinical data, suggesting clinical.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...